No Data
No Data
Cadrenal Therapeutics to Present at Inaugural Centri Capital Conference at Nasdaq
Express News | Cadrenal Therapeutics Inc - Files Prospectus Supplement for $2.17 Mln Atm Offering - SEC Filing
Is Cadrenal Therapeutics (NASDAQ:CVKD) In A Good Position To Deliver On Growth Plans?
Cadrenal Therapeutics Participates in Key Medical and Business Development Conferences
Cadrenal Therapeutics | 10-K: FY2024 Annual Report
Express News | Cadrenal Therapeutics FY 2024 GAAP EPS $(8.73) Misses $(7.59) Estimate